Graves' disease
RecruitingLong-Term Study of Imeroprubart in Adults With Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Italy- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Italy2 clinical trials in Pieve Emanuele, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Pioneering research focusing on metastatic prostate cancer treatment evaluation, combining surgical intervention with novel therapeutic approaches to improve patient outcomes.
Studies utilize cutting-edge PSMA-PET imaging technology to guide treatment decisions and monitor disease progression.
Innovative clinical research comparing imaging methodologies for monitoring metastatic breast cancer treatment responses and improving survival outcomes.
Research evaluates the effectiveness of FDG-PET/CT versus conventional CT scanning in treatment response monitoring.
Comprehensive evaluation of advanced imaging technologies in oncology diagnostics, focusing on precision medicine approaches.
Implementation of standardized evaluation criteria including PERCIST and RECIST methodologies for accurate disease monitoring.
Tell us about your condition – we search every trial in Europe and connect you with the right site.